CompletedPhase 2

Preoperative Percutaneous Radiofrequency Ablation of Primary and Secondary Lung Tumors

Germany9 participantsStarted 2004-04

Plain-language summary

The purpose of the study is to evaluate the effectiveness of radiofrequency ablation by pathological correlation and to characterize the tissue response after treatment of primary and secondary pulmonary tumors.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Signed informed consent for radiofrequency ablation and surgery * Maximum of 3 lung tumors * Maximum tumor size 5 cm * Must be able to receive standard surgery Exclusion Criteria: * Pathological coagulation tests * Pregnant or breast feeding * Maximum tumor size more than 5 cm * Bilateral secondary lung cancer with more than 3 tumors * Inoperable patient

What they're measuring

rate of incomplete treated tumors

Timeframe: 3 days

Trial details

NCT IDNCT00610844

SponsorUniversity Hospital Tuebingen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2006-05

View on ClinicalTrials.gov More Lung Cancer trials